InvivoSciences, Inc. (IVS)
Simulating Cardiac Fibrosis
Aug. 29, 2018- By: Elliot L. Elson;Hong Qian;Judy A. Fee;Tetsuro Wakatsuki
Courtesy ofInvivoSciences, Inc. (IVS)
InvivoSciences, Inc. is collaborating with Drs. Elson and Qian to establish a novel mathematical model to understand the development of cardiac fibrosis during heart failure. The model will be used to identify and validate new therapeutic targets to prevent, slow, or reverse cardiac fibrosis.
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.
